| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:2445-2453.)
© 2006 American Heart Association, Inc.
Vascular Medicine |
From Eli Lilly and Co, Indianapolis, Ind, and the Angiogenesis Research Center (M.S.), Dartmouth Medical School, Lebanon, NH.
Correspondence to JaiPal Singh, PhD, Eli Lilly and Co, Indianapolis, IN 46285. E-mail singh_jaipal{at}lilly.com
Received September 7, 2005; revision received March 20, 2006; accepted March 23, 2006.
Background The process of arteriogenesis after occlusion of a major artery is poorly understood. We have used high-resolution microcomputed tomography (µ-CT) imaging to define the arteriogenic response in the mouse model of hindlimb ischemia and to examine the effect of placental growth factor-1 (PlGF-1) on this process.
Methods and Results After common femoral artery ligation, µ-CT imaging demonstrated formation of collateral vessels originating near the ligation site in the upper limb and connecting to the ischemic calf muscle region. Three-dimensional µ-CT and quantitative image analysis revealed changes in the number of segments and the segmental volume of vessels, ranging from 8 to 160 µm in diameter. The medium-size vessels (48 to 160 µm) comprising 85% of the vascular volume were the major contributor (188%) to the change in vascular volume in response to ischemia. Intramuscular injections of Ad-PlGF-1 significantly increased Sca1+ cells in the circulation,
-actinstained vessels, and perfusion of the ischemic hindlimb. These effects were predominantly associated with an increase in vascular volume contributed by the medium-size (96 to 144 µm) vessels as determined by µ-CT.
Conclusions High-resolution µ-CT delineated the formation of medium-size collaterals representing a major vascular change that contributed to the restoration of vascular volume after ischemia. This effect is selectively potentiated by PlGF-1. Such selective enhancement of arteriogenesis by therapeutically administered PlGF-1 demonstrates a desirable biological activity for promoting the growth of functionally relevant vasculature.
This article has been cited by other articles:
![]() |
M. R. Distasi, J. Case, M. A. Ziegler, M. C. Dinauer, M. C. Yoder, L. S. Haneline, M. C. Dalsing, S. J. Miller, C. A. Labarrere, M. P. Murphy, et al. Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H877 - H886. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Penuelas, X. L. Aranguren, G. Abizanda, J. M. Marti-Climent, M. Uriz, M. Ecay, M. Collantes, G. Quincoces, J. A. Richter, and F. Prosper 13N-Ammonia PET as a Measurement of Hindlimb Perfusion in a Mouse Model of Peripheral Artery Occlusive Disease J. Nucl. Med., July 1, 2007; 48(7): 1216 - 1223. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |